Nazanin Khajoueinejad, MD (she/her/hers)
CGSO Fellow
Moffitt Cancer Center
Tampa, Florida, United States
Mokenge Malafa, MD
Moffitt Cancer Center
Tampa, Florida, United States
Jose M. Pimiento, MD, FACS (he/him/his)
Surgical Oncologist within the Department of Gastrointestinal Oncology
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
Jason W. Denbo, MD
Chief, Hepatobiliary Surgery
Moffitt Cancer Center
Tampa, Florida, United States
Daniel A. Anaya, MD, MSHCT
GI SURGICAL ONCOLOGY & GASTROENTEROLOGY
Moffitt Cancer Center
Tampa, Florida, United States
Andrew J. Sinnamon, MD
Surgical Oncologist within the Department of Gastrointestinal Oncology
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
Nazanin Khajoueinejad, MD (she/her/hers)
CGSO Fellow
Moffitt Cancer Center
Tampa, Florida, United States
Patient A is an 87-year-old female diagnosed with an ampullary adenoma not amenable to endoscopic resection identified on work up for dysphagia. Patient B is a 72-year-old female who presented with painless jaundice requiring ERCP and metal stent placement in setting of a resectable head of pancreas adenocarcinoma. Both patients underwent R0 resections and had uneventful recoveries postoperatively.
Between 2013 and 2025, 163 robotic pancreaticoduodenectomies have been performed at our institution. The majority of patients (63, 39%) were diagnosed with head of pancreas intraductal papillary mucinous neoplasm meeting guideline definitions for resection based on high-risk stigmata or worrisome features. 35 (21%) patients in the cohort were diagnosed with resectable head of pancreas adenocarcinoma. Over the 12-year period, we identified 10 (6%) complications specific to the hepaticojejunostomy including 4 (2%) bile leaks, and 4 (2%) biliary strictures. Median time to stricture formation was 5 years (range 6 days - 6 years). Two (1%) patients formed secondary biliary stones at 6 and 11 years after resection. These complications were managed with a combination of endoscopic retrograde cholangiopancreatography and percutaneous transhepatic drain placement.